GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 89 filers reported holding GW PHARMACEUTICALS PLC in Q4 2014. The put-call ratio across all filers is 1.09 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2017 | $348,000 | -26.4% | 3,471 | -11.3% | 0.01% | -23.1% |
Q1 2017 | $473,000 | -81.3% | 3,911 | -79.5% | 0.01% | -78.3% |
Q3 2016 | $2,528,000 | +493.4% | 19,047 | +309.0% | 0.06% | +566.7% |
Q2 2016 | $426,000 | -87.2% | 4,657 | -89.9% | 0.01% | -90.4% |
Q1 2016 | $3,321,000 | +227.2% | 46,024 | +456.8% | 0.09% | +422.2% |
Q2 2015 | $1,015,000 | +316.0% | 8,266 | +174.1% | 0.02% | +260.0% |
Q3 2014 | $244,000 | -83.1% | 3,016 | -77.6% | 0.01% | -77.3% |
Q2 2014 | $1,441,000 | – | 13,441 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
VHCP Management, LLC | 311,853 | $25,213,000 | 11.33% |
Iguana Healthcare Management, LLC | 50,000 | $4,043,000 | 2.16% |
Ghost Tree Capital, LLC | 35,000 | $2,830,000 | 1.54% |
CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD | 354,278 | $28,643,000 | 1.06% |
Cupps Capital Management, LLC | 100,213 | $8,102,000 | 0.75% |
CLOUGH CAPITAL PARTNERS L P | 192,600 | $15,572,000 | 0.58% |
FARALLON CAPITAL MANAGEMENT LLC | 244,000 | $19,727,000 | 0.32% |
CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD | 105,200 | $8,505,000 | 0.31% |
Eventide Asset Management | 25,000 | $2,021,000 | 0.28% |
PRUDENTIAL PLC | 836,124 | $67,601,000 | 0.28% |